Topics

Leading Independent Proxy Advisory Firm ISS Recommends Akebia Shareholders Vote “FOR” Proposed Merger with Keryx

07:00 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Akebia Urges Shareholders to Vote “FOR” the Merger-Related Shareholder Proposals Today Akebia Therapeutics, Inc. (Nasdaq:AKBA) (“Akebia” or the “Company”) today announced that leading independent proxy advisory f...

Other Sources for this Article

Akebia Therapeutics
Argot Partners
Melissa Forst / Maghan Meyers
(212) 600-1902

NEXT ARTICLE

More From BioPortfolio on "Leading Independent Proxy Advisory Firm ISS Recommends Akebia Shareholders Vote “FOR” Proposed Merger with Keryx"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...